Singapore markets close in 7 hours 31 minutes

Kronos Bio, Inc. (KRON)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.6900-0.0400 (-1.07%)
At close: 04:00PM EDT
3.6900 0.00 (0.00%)
After hours: 04:04PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 201.40M
Enterprise value -68.27M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.64
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.43

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-84.55%
S&P500 52-week change 3-9.13%
52-week high 325.7600
52-week low 32.9600
50-day moving average 34.1472
200-day moving average 310.7402

Share statistics

Avg vol (3-month) 3536.78k
Avg vol (10-day) 3843.31k
Shares outstanding 556.73M
Implied shares outstanding 6N/A
Float 843.41M
% held by insiders 115.55%
% held by institutions 166.59%
Shares short (30 May 2022) 44.6M
Short ratio (30 May 2022) 46.64
Short % of float (30 May 2022) 410.96%
Short % of shares outstanding (30 May 2022) 48.10%
Shares short (prior month 28 Apr 2022) 44.29M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-23.66%
Return on equity (ttm)-42.31%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -159.5M
Net income avi to common (ttm)-161.26M
Diluted EPS (ttm)-2.9230
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)303.14M
Total cash per share (mrq)5.34
Total debt (mrq)33.47M
Total debt/equity (mrq)10.56
Current ratio (mrq)18.19
Book value per share (mrq)5.66

Cash flow statement

Operating cash flow (ttm)-122.41M
Levered free cash flow (ttm)-70.26M